Literature DB >> 8678181

Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine.

A K Malhotra1, D Goldman, N Ozaki, A Breier, R Buchanan, D Pickar.   

Abstract

OBJECTIVE: The authors' goal was to determine whether either of two 5-HT2A receptor polymorphisms, 102-T/C and 452-His/Tyr, are associated with clozapine response.
METHOD: Brief Psychiatric Rating Scale (BPRS) ratings were obtained in 70 patients with schizophrenia or schizoaffective disorder to determine their response to clozapine compared with a typical neuroleptic. Patients were genotyped with the polymerase chain reaction and restriction fragment length polymorphism analysis.
RESULTS: Neither 102-T/C nor 452-His/Tyr was associated with clozapine response. There were no significant differences in BPRS scores among patients with different 5-HT2A genotypes at week 10 of clozapine administration.
CONCLUSIONS: Allelic variation in the 5-HT2A gene is not associated with individual differences in clozapine response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8678181     DOI: 10.1176/ajp.153.8.1092

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  26 in total

Review 1.  The challenges of psychopharmacogenetics.

Authors:  M Catalano
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

Review 2.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 3.  Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.

Authors:  Jian-Ping Zhang; Anil K Malhotra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-01       Impact factor: 4.481

4.  Pharmacogenetics of antipsychotic treatment response and side effects.

Authors:  B Mackenzie; Rp Souza; O Likhodi; Ak Tiwari; Cc Zai; J Sturgess; Dj Müller
Journal:  Therapy       Date:  2010-03

Review 5.  Predictors and markers of clozapine response.

Authors:  Carmen Chung; Gary Remington
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

6.  The future of pharmacotherapy for schizophrenia.

Authors:  John M Kane; Anil Malhotra
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

7.  Genes and schizophrenia: from a Festschrift Seminar honoring William T. Carpenter Jr, MD.

Authors:  Anil K Malhotra
Journal:  Schizophr Bull       Date:  2013-10-10       Impact factor: 9.306

8.  Genetic association studies in psychiatry. Are we putting the cart before the horse?

Authors:  P D Hrdina
Journal:  J Psychiatry Neurosci       Date:  1998-09       Impact factor: 6.186

Review 9.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03

Review 10.  Advances in pharmacogenomic research and development.

Authors:  Jeanette J McCarthy
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.